Clinical Trials for Hinova Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Hinova Pharmaceuticals

Clinical Trials (3)

NCT06757335
A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer
PHASE1/PHASE2Not yet recruiting
204 participants
Started: Jan 7, 2025 · Completed: Nov 27, 2026
1 condition1 sponsor0 locations
NCT06155084
A Phase I/II Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
PHASE1/PHASE2Recruiting
84 participants
Started: Dec 26, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor27 locations
NCT03851640
A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
PHASE3Recruiting
417 participants
Started: Apr 12, 2019 · Completed: Sep 30, 2025
1 condition1 sponsor1 location